Pigment-Dispersion Syndrome Treatments

Find Pigment-Dispersion Syndrome Treatments

Generic Name

Timolol

Brand Names
Betimol, Istalol, Timolol GFS, Timoptic, Timoptic-XE
FDA approval date: June 08, 1990
Classification: beta-Adrenergic Blocker
Form: Tablet, Solution

What is Betimol (Timolol)?

Betimol ® is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances

Related Clinical Trials

Adaptive Optics OCT Evaluation of Rhopressa's Effects on the Retinal Ganglion Cells in Glaucoma Patients

Summary: The purpose of this study is to compare how two FDA-approved eye drops: netarsudil (Rhopressa) and timolol, protect nerve cells in the eye of adults with open-angle glaucoma. Both medications lower pressure inside the eye, but researchers want to learn if Rhopressa is more effective at slowing down or preventing the loss of retinal ganglion cells. These cells are essential for sight because they c...

Efficacy of Topical 0.5% Timolol Solution for Healing Lower Extremity Wounds

Summary: Topical timolol, a β2-Adrenergic receptor (B2AR) antagonist, has demonstrated promise in wound healing over the past several years. The majority of the literature has evaluated the use of topical timolol to shorten wound healing time in chronic wounds of non-surgical etiologies. To date, there are no prospective randomized clinical trials evaluating the role of topical timolol for shortening wound...

Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Summary: Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Brand Information